|Articles|January 22, 2019

Current, New, and Emerging Therapies for the Prevention and Management of Migraine

https://www.pharmacytimes.org/on-demand/an-american-journal-of-managed-care-ajmc-2part-supplement-current-new-and-emerging-therapies-for-the-prevention-and-management-of-migraine

https://www.pharmacytimes.org/on-demand/an-american-journal-of-managed-care-ajmc-2part-supplement-current-new-and-emerging-therapies-for-the-prevention-and-management-of-migraine?rel=0" ?rel=0"

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Trending on AJMC

Current, New, and Emerging Therapies for the Prevention and Management of Migraine

Related Content

AI in Breast Cancer Care Outpaces Coverage and Guidelines

CMS Proposes Major Reforms to Medicare ACOs and Physician Pay

GLP-1 Use in Youth Climbs as Bariatric Surgery Rates Fall

Tec-Dara Closes Survival Gap in High-Risk MM: Rahul Banerjee, MD

Access Barriers, Not Science, Slow Retina Care: Paul Hahn, MD

Trending on AJMC

Medicaid MFN Pricing Could Save $8.6 Billion

CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks

Active US Drug Shortages Rise for Third Straight Quarter

Access Barriers, Not Science, Slow Retina Care: Paul Hahn, MD

Early-Onset CKD Mortality Declines Globally as Incidence Continues to Rise